🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
The purpose of this study is to see whether subjects with gout who receive ...
Status
Completed
Location
Multiple Locations
Start Date
2010-04-23
Trial ID
NCT01101035
Treatments Being Tested
This study will assess the bioequivalence (BE) of Lesinurad/Allopurinol Fix...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-30
Trial ID
NCT02888054
Treatments Being Tested
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
This study will assess the serum uric acid lowering effects and safety of l...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01808131
Acute myeloid leukaemia (AML) is a clonal haematological malignancy charact...
Status
Not Yet Recruiting
Location
National University of Medical Sciences, Clinical Trial Unit
Start Date
2026-08-01
Trial ID
NCT07748455
The purpose of this clinical research study is to establish the dose of ver...
Status
Completed
Location
Research Site
Start Date
2019-07-23
Trial ID
NCT03990363
Treatments Being Tested
This study that compare the serum uric acid lowering effects, clinical bene...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01510158
Treatments Being Tested
RATIONALE: Giving chemotherapy, such as cyclophosphamide and fludarabine, a...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2008-03
Trial ID
NCT00652899